A FDA advisory panel urged Acrotech Biopharma to accelerate the release of trial data that could confirm benefits of its blood cancer drugs.
Click here to view original post
News
Red Mesa Science & Refining Upends Hemp Sector With Novel Botanical Refinement to Isolate Rare Cannabinoids
ST. GEORGE, Utah–(BUSINESS WIRE)–Amid rapidly evolving cannabinoid-product and CPG industries, Red Mesa Science & Refining has announced a monumental breakthrough in hemp-derived cannabinoid processing. With the introduction of its botanical refinement method, the company has […]
News
Innovative Pilot Program to Support Children Suffering Loss of Caregiver Launches in Utah
Children’s Collaborative for Healing and Support announces additional $1 million investment from the New York Life Foundation to kickstart Utah initiative SALT LAKE CITY, May 31, 2023 /PRNewswire/ — A first-of-its-kind initiative built on community […]
News
Employees Spend Up to $1,500 Out of Pocket as Employer Benefits Miss the Mark, Castlight Survey Finds
36% seek their own tools first and nearly half use consumer health apps as static, hard‑to‑navigate benefits fail to keep pace with employee needs SANDY, Utah, April 28, 2026 /PRNewswire/ — Castlight Health, a leader […]
